About

Publications While At HealthPartners

selected publications

Journal Article

Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas. 

Neurooncol Adv. 2023

Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies. 

British Journal of Cancer. 2023

Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy. 

Breast Cancer Research and Treatment. 2020

Phase Ib/II clinical trial of pembrolizumab with bevacizumab for metastatic renal cell carcinoma: BTCRC-GU14-003. 

Journal of Clinical Oncology. 2020

Phase I study of IGF-methotrexate conjugate in the treatment of advanced tumors expressing IGF-1R. 

American Journal of Clinical Oncology. 2019

Phase I study of aurora A kinase inhibitor alisertib (MLN8237) in combination with selective VEGFR inhibitor pazopanib for therapy of advanced solid tumors. 

American Journal of Clinical Oncology. 2019

Contact

full name

L. C. Liu

Quick Info

 

Collaboration

Co-author network

Map of science